Your account is not claimed yet. You can sign up with ORCID to claim your account.

Christopher J Morris (Chris J Morris)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Newly Diagnosed

Top Venues

Pathogens (Basel, Switzerland)

Beilstein journal of nanotechnology

University of East Anglia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of East Anglia

United Kingdom

Lecturer

Publications

Christopher J Morris, Jennifer L Rohn, Scott Glickman, Kylie J Mansfield
Effective Treatments of UTI-Is Intravesical Therapy the Future? Pathogens (Basel, Switzerland) 12 (3) (2023)
Christopher J Morris, Jennifer L Rohn, Scott Glickman, Kylie J Mansfield
Effective Treatments of UTI-Is Intravesical Therapy the Future? Pathogens (Basel, Switzerland) 12 (3) (2023)
Christopher J Morris, Jennifer L Rohn, Scott Glickman, Kylie J Mansfield
Effective Treatments of UTI-Is Intravesical Therapy the Future? Pathogens (Basel, Switzerland) 12 (3) (2023)
Mohammad J Akbar, Pamela Cristina Lukasewicz Ferreira, Melania Giorgetti, Leanne Stokes, Christopher J Morris
Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells. Beilstein journal of nanotechnology 10 (2019)